In ERα-positive cancer, estrogen signaling has been reported to suppress p53 activity, which inhibits apoptosis induced by chemotherapy and causes resistance [28], suggesting the importance of estrogen signaling in the pathobiology of p53. The gene discussed is ESR1; the disease is cancer.